Friday, May 15, 2026

Trump’s New Defense Strategy: Why Seoul Is Expected to Lead Deterrence as 28,500 U.S. Troops Stay Put

The new U.S. National Defense Strategy emphasizes South Korea's military capabilities and shifts responsibilities in countering North Korea.

KIM’S ‘REALITY SHOW’: North Korea Turns Dictatorship Into Sickening ‘Toddler TV’ With 600 Days Of Airtime

AI analysis shows Kim Ju Ae on screen for over 200 days yearly, highlighting her role as a potential successor to Kim Jong Un.

Mystery Trip: North Korea’s Safety Officials Fly to Russia Amid Speculation

A North Korean delegation led by Bang Du-seop has departed Pyongyang for a visit to Russia, as reported by the Workers' Party newspaper.

Tag: Elevar Therapeutics

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Top News

- Our Sponsors Ad -

Follow us